Академический Документы
Профессиональный Документы
Культура Документы
sciel
Mi SciELO
Servicios personalizados
Servicios Personalizados
Artículo
Artículo en XML
Traducción automática
Indicadores
Links relacionados
Bookmark
DNA methylation:
an epigenetic process of medical
importance
Reimpresos:
ABSTRACT
RESUMEN
INTRODUCCIÓN
Represión transcripcional
IMPRONTA GENÓMICA
Síndrome ICF
Síndrome de Rett
Síndrome ATRX
Síndrome de X frágil
CONCLUSIONES Y PERSPECTIVAS
AGRADECIMIENTOS
Agradecemos al Dr. Rubén Lisker la revisión y comentarios al
manuscrito.
REFERENCIAS
1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton
GG, et al. The sequence of the human genome. Science 2001;
291: 1304-51. [ Links ]
12. Bird AP, Taggart MH, Nicholls RD, Higgs DR. None-
methylated CpG-rich islands at the human a globin locus:
implications for evolution of the a globin pseudogene. EMBO J
1987; 6: 999-1004. [ Links ]
13. McKeon C, Ohkubo H, Pastan I, de Crombrugghe B. Unusual
methylation pattern of the a 2(1) collagen gene. Cell 1982; 29:
203-10. [ Links ]
23. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G, Li BF. Human
DNA-(cytosine-5) methyltransferase-PCNA complex as a target
for p21WAF1. Science 1997; 277: 1996-2000. [ Links ]
29. Wolffe AP, Jones PL, Wade PA. DNA demethylation. Proc Natl
Acad Sci USA 1999; 96: 5894-6. [ Links ]
38. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP.
Identification of a mammalian protein that binds specifically to
DNA containing methylated CpGs. Cell 1989; 58: 499-507. [
Links ]
39. Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG
binding domain from the chromosomal protein MeCP2. Nucleic
Acids Res 1993; 21: 4886-92. [ Links ]
45. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U,
Zoghbi HY. Rett syndrome is caused by mutations in X-linked
MECP2, encoding methyl-CpG binding protein 2. Nat Genet
1999; 23: 185-8. [ Links ]
47. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU,
Landsberger N, StrouboulisJ, Wolffe AP. Methylated DNA and
MeCP2 recruit histone deacetylase to repress transcription. Nat
Genet 1998; 19: 187-91. [ Links ]
57. Nakayama J, Rice JC, Strahl BD, Allis CD, Grewald SI. Role
of histone H3 lysine 9 methylation in epigenetic control of
heterochromatin assembly. Science 2001; 292: 110-3. [ Links ]
72. Boumil RM, Lee JT. Forty years of decoding the silence in X-
chromosome inactivation. Hum Mol Genet 2001 10: 2225-32. [
Links ]
82. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM,
Tilghman SM. CTCF mediates methylation sensitive enhancer-
blocking activity at the H19/Igf2 locus. Nature 2000; 405: 486-
9. [ Links ]
94. Webb T, Latif F. Rett syndrome and the MECP2 gene. J Med
Genet 2001; 38: 217-23. [ Links ]
99. Orrico A, Lam CW, Galli L, Dotti MT, Hayek G, Tong SF, Poon
PMK, Zapella M, Federico A, Sorrentino V. MECP2 mutation in
male patients with non specific X-linked mental retardation.
FEBS Lett 2000; 481: 285-8. [ Links ]
100. Picketts DJ, Higgs DR, Bachhoo S, Blake DJ, Quarrell OW,
Gibbons RJ. ATRX encodes a novel member of the SNF2 family
of proteins: mutations point to a common mechanism
underlying the ATR-X syndrome. Hum Mol Genet 1996; 5: 1899-
907. [ Links ]
105. Vertek AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti
A, Reiner O, Richards S, Victoria MF, Zhang FP, et al.
Identification of a gene (FMR-1) containing a CGG repeat
coincident with a breakpoint cluster region exhibiting length
variation in fragile X syndrome. Cell 1991; 65: 905-14. [ Links ]
109. De Baun MR, Niemitz EL, Mc Neil DE, Bradenburg SA, Lee
MP, Freinberg AP. Epigenetic alterations of H19 and LIT1
distinguish patients with Beckwith-Wiedemann syndrome with
cancer and birth defects. Am J Hum Genet 2002; 70: 604-11. [
Links ]
119. Garinis GA, Patrinos GP, Spanakis NE, Menounos PG. DNA
hypermethylation: when tumour suppressor genes go silent.
Hum Genet 2002; 111: 115-27. [ Links ]
RIC@quetzal.innsz.mx